MSFT   212.19 (-0.99%)
FB   241.25 (-1.33%)
GOOGL   1,505.56 (-0.86%)
AMZN   3,178.53 (-0.13%)
CGC   16.15 (+0.81%)
BABA   257.02 (-1.74%)
TSLA   1,388.51 (-0.41%)
AMD   57.05 (-0.37%)
T   29.75 (+0.71%)
ACB   11.89 (+1.02%)
GILD   76.15 (+1.93%)
DIS   117.72 (+0.77%)
BA   174.17 (+0.51%)
MSFT   212.19 (-0.99%)
FB   241.25 (-1.33%)
GOOGL   1,505.56 (-0.86%)
AMZN   3,178.53 (-0.13%)
CGC   16.15 (+0.81%)
BABA   257.02 (-1.74%)
TSLA   1,388.51 (-0.41%)
AMD   57.05 (-0.37%)
T   29.75 (+0.71%)
ACB   11.89 (+1.02%)
GILD   76.15 (+1.93%)
DIS   117.72 (+0.77%)
BA   174.17 (+0.51%)
MSFT   212.19 (-0.99%)
FB   241.25 (-1.33%)
GOOGL   1,505.56 (-0.86%)
AMZN   3,178.53 (-0.13%)
CGC   16.15 (+0.81%)
BABA   257.02 (-1.74%)
TSLA   1,388.51 (-0.41%)
AMD   57.05 (-0.37%)
T   29.75 (+0.71%)
ACB   11.89 (+1.02%)
GILD   76.15 (+1.93%)
DIS   117.72 (+0.77%)
BA   174.17 (+0.51%)
MSFT   212.19 (-0.99%)
FB   241.25 (-1.33%)
GOOGL   1,505.56 (-0.86%)
AMZN   3,178.53 (-0.13%)
CGC   16.15 (+0.81%)
BABA   257.02 (-1.74%)
TSLA   1,388.51 (-0.41%)
AMD   57.05 (-0.37%)
T   29.75 (+0.71%)
ACB   11.89 (+1.02%)
GILD   76.15 (+1.93%)
DIS   117.72 (+0.77%)
BA   174.17 (+0.51%)
Log in

NASDAQ:PCRXPacira Biosciences News Headlines

$57.74
+0.21 (+0.37 %)
(As of 07/10/2020 09:51 AM ET)
Add
Compare
Today's Range
$56.86
Now: $57.74
$58.00
50-Day Range
$42.53
MA: $46.55
$56.54
52-Week Range
$27.46
Now: $57.74
$58.19
Volume75,302 shs
Average Volume918,250 shs
Market Capitalization$2.43 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.31

Headlines

Pacira Biosciences (NASDAQ PCRX) News Headlines

Source:
DateHeadline
Jefferies Financial Group Increases Pacira Biosciences (NASDAQ:PCRX) Price Target to $69.00Jefferies Financial Group Increases Pacira Biosciences (NASDAQ:PCRX) Price Target to $69.00
www.marketbeat.com - July 10 at 8:23 AM
Jefferies Financial Group Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $69.00Jefferies Financial Group Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $69.00
www.americanbankingnews.com - July 10 at 8:21 AM
Pacira Bio prices $350M convertible debt offeringPacira Bio prices $350M convertible debt offering
seekingalpha.com - July 8 at 8:43 AM
Pacira Bio prices upsized convertible debt offeringPacira Bio prices upsized convertible debt offering
seekingalpha.com - July 8 at 8:43 AM
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
finance.yahoo.com - July 7 at 11:00 PM
Pacira Biosciences Inc (NASDAQ:PCRX) Receives Average Rating of "Buy" from AnalystsPacira Biosciences Inc (NASDAQ:PCRX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 7 at 1:44 AM
Pacira Biosciences (NASDAQ:PCRX) Sets New 12-Month High Following Analyst UpgradePacira Biosciences (NASDAQ:PCRX) Sets New 12-Month High Following Analyst Upgrade
www.marketbeat.com - July 6 at 6:17 PM
Pacira BioSciences under pressure on preliminary Q2 resultsPacira BioSciences under pressure on preliminary Q2 results
seekingalpha.com - July 6 at 6:00 PM
Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020
finance.yahoo.com - July 6 at 6:00 PM
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior NotesPacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes
finance.yahoo.com - July 6 at 6:00 PM
Pacira Biosciences (NASDAQ:PCRX) Price Target Raised to $64.00 at Needham & Company LLCPacira Biosciences (NASDAQ:PCRX) Price Target Raised to $64.00 at Needham & Company LLC
www.americanbankingnews.com - July 6 at 8:59 AM
Pacira Biosciences (NASDAQ:PCRX) Earns Overweight Rating from Piper SandlerPacira Biosciences (NASDAQ:PCRX) Earns Overweight Rating from Piper Sandler
www.americanbankingnews.com - July 6 at 8:24 AM
Wedbush Reaffirms Buy Rating for Pacira Biosciences (NASDAQ:PCRX)Wedbush Reaffirms Buy Rating for Pacira Biosciences (NASDAQ:PCRX)
www.americanbankingnews.com - July 3 at 10:56 AM
FY2021 EPS Estimates for Pacira Biosciences Inc (NASDAQ:PCRX) Increased by SVB LeerinkFY2021 EPS Estimates for Pacira Biosciences Inc (NASDAQ:PCRX) Increased by SVB Leerink
www.americanbankingnews.com - July 2 at 10:13 AM
Pacira BioSciences Announces Conclusion of EXPAREL Agreement with DePuy SynthesPacira BioSciences Announces Conclusion of EXPAREL Agreement with DePuy Synthes
finance.yahoo.com - July 2 at 9:57 AM
Pacira Biosciences Inc (NASDAQ:PCRX) SVP Charles Anthony Laranjeira Sells 60,101 SharesPacira Biosciences Inc (NASDAQ:PCRX) SVP Charles Anthony Laranjeira Sells 60,101 Shares
www.americanbankingnews.com - July 2 at 12:04 AM
Pacira Biosciences Inc (NASDAQ:PCRX) VP Lauren Bullaro Riker Sells 6,000 SharesPacira Biosciences Inc (NASDAQ:PCRX) VP Lauren Bullaro Riker Sells 6,000 Shares
www.marketbeat.com - July 1 at 11:32 PM
Royal Bank of Canada Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $62.00Royal Bank of Canada Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $62.00
www.marketbeat.com - July 1 at 9:03 AM
SVB Leerink Research Analysts Lift Earnings Estimates for Pacira Biosciences Inc (NASDAQ:PCRX)SVB Leerink Research Analysts Lift Earnings Estimates for Pacira Biosciences Inc (NASDAQ:PCRX)
www.americanbankingnews.com - July 1 at 7:28 AM
Pacira Biosciences (NASDAQ:PCRX) Price Target Increased to $58.00 by Analysts at SVB LeerinkPacira Biosciences (NASDAQ:PCRX) Price Target Increased to $58.00 by Analysts at SVB Leerink
www.americanbankingnews.com - June 30 at 10:56 AM
Northland Securities Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $54.00Northland Securities Raises Pacira Biosciences (NASDAQ:PCRX) Price Target to $54.00
www.americanbankingnews.com - June 30 at 10:25 AM
Pacira BioSciences surges after Heron receives CRLPacira BioSciences surges after Heron receives CRL
seekingalpha.com - June 29 at 1:16 PM
Why Pacira BioSciences Is Soaring TodayWhy Pacira BioSciences Is Soaring Today
www.fool.com - June 29 at 1:16 PM
U.S. FDA seeks more data on Heron Therapeutics' non-opioid painkillerU.S. FDA seeks more data on Heron Therapeutics' non-opioid painkiller
finance.yahoo.com - June 29 at 1:16 PM
Zacks: Analysts Anticipate Pacira Biosciences Inc (NASDAQ:PCRX) Will Post Quarterly Sales of $52.95 MillionZacks: Analysts Anticipate Pacira Biosciences Inc (NASDAQ:PCRX) Will Post Quarterly Sales of $52.95 Million
www.americanbankingnews.com - June 27 at 4:12 AM
Pacira Biosciences Inc (NASDAQ:PCRX) Expected to Post Earnings of -$0.23 Per SharePacira Biosciences Inc (NASDAQ:PCRX) Expected to Post Earnings of -$0.23 Per Share
www.americanbankingnews.com - June 25 at 5:53 AM
Very Critical News Coverage Extremely Likely to Impact Pacira Biosciences (NASDAQ:PCRX) Stock PriceVery Critical News Coverage Extremely Likely to Impact Pacira Biosciences (NASDAQ:PCRX) Stock Price
www.americanbankingnews.com - June 18 at 11:05 PM
Pacira BioSciences to Present at the 2020 BMO Prescriptions for Success Healthcare ConferencePacira BioSciences to Present at the 2020 BMO Prescriptions for Success Healthcare Conference
finance.yahoo.com - June 16 at 8:12 AM
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
finance.yahoo.com - June 10 at 5:32 PM
Pacira BioSciences to Present at the 2020 Jefferies Virtual Healthcare ConferencePacira BioSciences to Present at the 2020 Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 27 at 9:46 AM
Sandell buys Taubman, exits Pacira BioSciencesSandell buys Taubman, exits Pacira BioSciences
seekingalpha.com - May 15 at 11:44 AM
Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual ConferencePacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 13 at 11:18 AM
Paciras (PCRX) Q1 Earnings Top Estimates, Revenues Rise Y/YPacira's (PCRX) Q1 Earnings Top Estimates, Revenues Rise Y/Y
www.nasdaq.com - May 8 at 6:27 PM
Pacira BioSciences EPS beats by $0.23, beats on revenuePacira BioSciences EPS beats by $0.23, beats on revenue
seekingalpha.com - May 7 at 1:14 PM
Pacira BioSciences Reports First Quarter 2020 Financial Results and Business UpdatePacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
finance.yahoo.com - May 7 at 8:13 AM
Pacira Pharmaceuticals Q1 2020 Earnings PreviewPacira Pharmaceuticals Q1 2020 Earnings Preview
seekingalpha.com - May 6 at 6:18 PM
Pacira BioSciences Appoints Donald C. Manning, M.D., Ph.D. as Chief Medical OfficerPacira BioSciences Appoints Donald C. Manning, M.D., Ph.D. as Chief Medical Officer
finance.yahoo.com - May 4 at 2:42 PM
Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020
finance.yahoo.com - May 2 at 1:22 PM
Why Pacira BioSciences, Inc.s (NASDAQ:PCRX) CEO Pay Matters To YouWhy Pacira BioSciences, Inc.'s (NASDAQ:PCRX) CEO Pay Matters To You
finance.yahoo.com - April 24 at 8:39 AM
Why Pacira BioSciences, Inc.'s (NASDAQ:PCRX) CEO Pay Matters To YouWhy Pacira BioSciences, Inc.'s (NASDAQ:PCRX) CEO Pay Matters To You
finance.yahoo.com - April 23 at 12:38 PM
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
finance.yahoo.com - April 7 at 5:09 PM
How This Top Fund Manager Seeks Stocks That Benefit From The Coronavirus Stock MarketHow This Top Fund Manager Seeks Stocks That Benefit From The Coronavirus Stock Market
finance.yahoo.com - April 6 at 3:46 PM
Pacira (PCRX) Down 37.2% Since Last Earnings Report: Can It Rebound?Pacira (PCRX) Down 37.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 21 at 2:28 PM
Why You Shouldnt Bet Against Pacira BioSciences (PCRX) StockWhy You Shouldn't Bet Against Pacira BioSciences (PCRX) Stock
www.nasdaq.com - March 17 at 3:04 PM
Why You Shouldn't Bet Against Pacira BioSciences (PCRX) StockWhy You Shouldn't Bet Against Pacira BioSciences (PCRX) Stock
finance.yahoo.com - March 17 at 3:04 PM
PCRX or ZTS: Which Is the Better Value Stock Right Now?PCRX or ZTS: Which Is the Better Value Stock Right Now?
finance.yahoo.com - March 13 at 3:57 PM
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons WhyPacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why
finance.yahoo.com - March 13 at 3:57 PM
Why Pacira (PCRX) Could Be an Impressive Growth StockWhy Pacira (PCRX) Could Be an Impressive Growth Stock
finance.yahoo.com - March 10 at 2:18 PM
Pacira BioSciences to Present at the 2020 Barclays Global Healthcare ConferencePacira BioSciences to Present at the 2020 Barclays Global Healthcare Conference
finance.yahoo.com - March 9 at 7:52 AM
Oversold Conditions For Pacira BioSciences (PCRX)Oversold Conditions For Pacira BioSciences (PCRX)
www.nasdaq.com - March 6 at 12:58 PM
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.